A novel acyl-CoA : cholesterol acyltransferase (ACAT) inhibitor, designated epi-cochlioquinone A has been isolated from the fermentation broth of Stachybotrys bisbyi SANK17777. The molecular formula, physicochemical properties, NMRspectroscopic analysis and X-ray crystallographic analysis revealed that this compoundwas a stereoisomer of cochlioquinone A, which has been previously reported as a nematocidal agent. It inhibited ACATactivity in an enzyme assay using rat liver microsomes with an IC50 value of 1.7pu. However, it showed about 10-fold less potent inhibitory effect on plasma lecithin cholesterol acyltransferase (LCAT) than on ACAT. In addition, it inhibited in vivo cholesterol absorption in rats by 50% at 75mg/kg.
A novel acyl-CoA : cholesterol acyltransferase (ACAT) inhibitor, designated epi-cochlioquinone A has been isolated from the fermentation broth of Stachybotrys bisbyi SANK17777. The molecular formula, physicochemical properties, NMRspectroscopic analysis and X-ray crystallographic analysis revealed that this compoundwas a stereoisomer of cochlioquinone A, which has been previously reported as a nematocidal agent. It inhibited ACATactivity in an enzyme assay using rat liver microsomes with an IC50 value of 1.7pu. However, it showed about 10-fold less potent inhibitory effect on plasma lecithin cholesterol acyltransferase (LCAT) than on ACAT. In addition, it inhibited in vivo cholesterol absorption in rats by 50% at 75mg/kg. Eagle's medium (DMEM) was from Nissui Pharmaceutical Corp., and fetal bovine serum (FBS) was from Gibco. Fatty acid-free bovine serum albumin (BSA) was obtained from Sigma. All other chemicals were of the highest grade commercially available.
Acyl

Spectroscopic Studies
The UVspectrum was recorded on a Shimadzu UV-200S spectrophotometer. IR spectral data was recorded using a JASCO FT-IR 5SXC infrared spectrometer.
Optical rotation was obtained with a JASCODIP-370 digital polarimeter. The EI-MS spectrum recorded on a JEOL JMS-D100 mass spectrometer at 20eV. NMR spectra were obtained on a JEOL JNM-GX-400spec-trometer at 400 and 125 MHzfield strengths for *H and 13C nuclei, respectively.
Single Crystal X-Ray Analysis Epi-cochlioquinone A was recrystalized from isopropylether. The yellow plate crystal having an approximate dimension of0.7 x 0.3 x 0.15mmwasmounted on a glass fibre. All measurementswere madeon a Rigaku AFC-5R diffractometer with graphite monochromated CuXa radiation. The data were collected at a temperature of 25°C using a w-2q scan technique to a maximum2q value of 130°. Pertinet crystal, data collection, and refinement parameters are summarized in Table 4 . The structure was solved by direct methods using MULTAN 782), and refined by the block diagonal least-squares technique with anisotropic thermal parameters. Atomic scattering factors were taken from the previous report3).
Calculations were carried out with the DIRECT-SEARCH program system.
Assay of Microsomal ACATActivity
Microsomesprepared from rat liver were used as a source of ACATand the activity was determined as described elsewhere4) with modifications. Experimentally, rat liver microsomes ( Cholesteryl Ester Formation in J774 Macrophage Human LDL (1.019<d< 1.063) and lipoprotein-deficient serum (d> 1.25) were prepared from plasma of healthy normolipidemic subjects by sequential ultracentrifugation5).
J774 cells were maintained in monolayer in DMEM containing lOOU/ml penicillin and 100/ig/ml streptomycin supplemented with 10% heatinactivated FBS. On day 0, 1.0 x 106 cells were inoculated into 6-well plates (Corning) in 2ml medium supplemented with 10% FBS and incubated at 37°C for 18 hours in a humidified 5% CO2/95%air atomosphere.
On day 1, each monolayer was washed with phosphatebuffered saline, and incubated in DMEM (supplemented Assay of Plasma LCATActivity LCATactivity was assayed by the method of Stokke and Norum7).
Measurement of Cholesterol Absorption in Rats
Groups of 4 male Sprague-Dawley rats (6 weeks old, Charles River, Japan) were fed on a 1.5% cholesterol and 0.5% cholate-supplemented chow diet for 3 days. On day 3, varying doses of epi-cochlioquinone A were orally administered as a suspension in a 1%Tween80
solution.
[l,2-3H]Cholesterol (1.85MBq) was orally administered at 30 minutes after the drug dosage. Blood was withdrawn by cardiac puncture at 4 hours after the isotope dosing. Serum was prepared by centrifugation, and radioactivity in serum was determined.
Results
Taxonomy
Epi-cochlioquinone A producing strain SANK17777 was isolated from soil sample collected in Okinawa. The mycological properties of the strain SANK17777 were observed to be as follows. Growth on oat meal agar plate was rapid, covering a Petri dish plate in 2 weeks at 25°C. The texture of the colony was velvety to a fine powdery form, salmon-pinkin color; at the center of the colony a downywhite mycelium was developed. Conidiophores were determinate, produced solitary or in groups. They were straight, simple or branched, composedof 2 to 5 cells. The surface of the conidiophores were sometimes minutely rough-walled. Phialides were born at the tip of condiohiores, produced in a whorl of 3 to 8 in number. 
Fermentation
A slant culture of Stachybotrys bisbyi grown on WSH agar (crushed oat meal 1.0%, NaNO3 0.1%, KH2PO4 0.1%, MgSO4 (7H2O 0.25% and agar 2.0% without adjustment of pH) was used to inoculate 500-ml buffled Erlenmeyer flasks containing 100 ml of the seed medium VOL.49 NO.5 THE JOURNAL OF ANTIBIOTICS (GPMY; glycerol 5%, potatoes 5%, malt extract 0.5% and yeast extract 0.5% in tap water without adjustment of pH). The flasks were shaken on a rotary shaker for 3 days at 26°C. Twomilliliters of the seed culture were transferred into 100ml of a GPMYmedium in 500-ml buffled Erlenmeyer flasks. The flasks were shaken on a rotary shaker for 7 days at 26°C. The production of epi-cochlioquinone A was measured by HPLCunder the following conditions:
Waters Radial-Pak ODS 8NVC184, 4.6mm x 150mm; 55% acetonitrile-H2O, at 2ml/minute; UV detection at 210nm. Epi-cochlioquinone A was eluted with a retention time of 7.0 minutes.
Isolation
After filtration of the cultured broth (1.3 liters), the filtrate was extracted with ethyl acetate in an acidic condition. The mycelium obtained was extracted with 1.3 liters of acetone. After the acetone extracts were filtered and concentrated, the resulting aqueous solution was also extracted with ethyl acetate in an acidic condition. The combined organic phase was washed with 3% NaHCO3and dried over Na2SO4. The extracts were concentrated in vacuo to dryness to yield a brown oil (294 mg). The crude extract was chromatographed with reverse phase HPLC (Senshu Pak ODS-H-5251, 20x250mm) using acetonitrile- H2O (65:35) as the eluent at 6.0 ml/minute. The peak of epi-cochlioquinone A was collected, evaporated and recrystallized with a mixture of^-hexane and acetone to yield a 90 mgcrystal. Characterization and Structure Determination of Epi-cochlioquinone A Epi-cochlioquinone A appears as yellow crystal and its physico-chemical properties are summarized in Table   1 . The compoundis soluble in alcoholic solvents, acetone, (Table 2) , which were classified into seven -CH3, five -CH2, three -CH-, four -O-GH-, one -CH= and ten quaternary carbons by analysis of DEPTspectra. The *H NMRspectrum displayed 44 proton signals (Table   3) . These results supported the molecular formula. The structure ofepi-cochlioquinone A is shown in Fig.   1 . Physico-chemical properties of epi-cochlioquinone A were similar to those of cochlioquinone A9). However, epi-cochlioquinone A had a higher melting point; 1581 61°C for epi-cochlioquinone A versus 130~132°C for cochlioquione A. In addition, compared with NMRdata of cochlioquinone A8), the methyl protons at the 19-position (10-CH3, SH 0.64) of epi-cochlioquione A showed higher field shift than those of cochlioquinone A (<5H 1.02). From these data, the two compounds described above seemed to be stereoisomers. The structure of epi-cochlioquinone A was confirmed by single crystal X-ray analysis. X-Ray crystallographic analysis of epi-cochlioquinone A is summarized in Table   4 . The non-hydrogen atoms were refined anisotropically. The final cycle of block-diagonal least-squares refinement was based on 2359 observed reflections and 519 The sample was dissolved in CDC13. Chemical shifts are shown with reference to TMSas Oppm. variable parameters of R=0.044, Rw=0.043. Thus, the structure of epi-cochlioquinone A described above has been confirmed and the relative configuration wasalso determined as shown in Fig. 2 . From the result ofX-ray crystallographic analysis, the methyl group attached to the C-8 atom of epi-cochlioquinone A was deduced to exist as the cis isomer in relation to the pendant C-9 hydrogen atom, while cochlioquinone A was confirmed The biological properties of epi-cochlioquinone A are summarized in Table 5 . Epi-cochlioquinone A inhibited microsomal ACATactivity by 50% at a concentration of 1.7/jm. It inhibited plasma LCATactivity by 50% at 15.8 fiM. It was also evaluated in the cell ACATassay in J774 macrophages. Cholesteryl ester formation was inhibited in a dose-dependent manner (data not shown)
with an IC50 value of 16.0//m. In cholesterol-fed rats, epi-cochlioquinone A inhibited cholesterol absorption with an ED50 value of 75mg/kg (Fig. 3) . No acute toxicity was observed up to 2000mg/kg po in mice.
Discussion
Epi-cochlioquinone
A is a stereoisomer of cochlioquinone A, which has a steroid-like structure and was reported to have nematocidal activity11}. Whether or not cochlioquinone A has ACATinhibitory activity is unknown, since cochlioquinone A was not isolated from the fermentation broth of Stachybotrys bisbyi SANK 17777. Epi-cochlioquinone A did not show nematocidal activity against Caemarhabditis elegans at 2 fiM (data not shown).
A showed about a 10-fold less potent inhibitory effect on plasma LCATactivity than on ACAT. Since LCAT is a critical enzyme for cholesterol reverse transport from peripheral tissues or arterial lesions to the liver12), the selective inhibition shown by epi-cochlioquinone A is favorable for regression of arterial lesions. Another target organ of ACATinhibitors is the intestine. Inhibition of ACAT activity in intestine results in suppression of cholesterol absorption followed by reduction of plasma cholesterol levels. Epi-cochlioquinone A inhibited cholesterol absorption in cholesterol-fed rats. An investigation of the plasma cholesterol-lowering effect through a mechanism of inhibition of intestinal ACATby epi-cochlioquinone A is now in progress.
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